Cytosorbents Corp
CTSO
72 hedge funds and large institutions have $34.4M invested in Cytosorbents Corp in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 10 closing their positions.
80% more capital inflows, than outflows
Capital inflows: $4.4M | Capital outflows: $2.45M
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
10% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 20
4% more funds holding
Funds holding: 69 → 72 (+3)
1.42% more ownership
Funds ownership: 26.16% → 27.58% (+1.4%)
98% less call options, than puts
Call options by funds: $1K | Put options by funds: $60K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.3M |
| 2 |
Two Sigma Investments
New York
|
+$474K |
| 3 |
Anson Funds Management
Dallas,
Texas
|
+$325K |
| 4 |
D.E. Shaw & Co
New York
|
+$221K |
| 5 |
Skylands Capital
Milwaukee,
Wisconsin
|
+$181K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$661K |
| 2 |
Raymond James & Associates
St Petersburg,
Florida
|
-$334K |
| 3 |
NXG Investment Management
Dallas,
Texas
|
-$233K |
| 4 |
CPP
Crow Point Partners
Boston,
Massachusetts
|
-$214K |
| 5 |
Granite Investment Partners
El Segundo,
California
|
-$163K |
CTSO Hedge Fund Activity: Q4 2019 in Review
72 of the 5,094 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2019, worth a combined $34.4M — down 19% from $42.5M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CTSO positions and 10 closed out — a net gain of 3 holders — while 22 added to existing stakes and 20 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.3M. The largest seller was Allianz Asset Management, exiting entirely with an estimated $661K sold.
- 72 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2019, up from 69 in Q3 2019.
- Funds reported $34.4M of Cytosorbents Corp stock for Q4 2019, down 19% quarter-over-quarter.
- 13 funds opened new Cytosorbents Corp positions in Q4 2019 and 10 closed out, a net change of +3 holders.
- The largest Cytosorbents Corp buyer in Q4 2019 was Morgan Stanley, an estimated $1.3M added.
- The largest Cytosorbents Corp seller in Q4 2019 was Allianz Asset Management, an estimated $661K sold.
Based on aggregated 13F filings for Q4 2019.